Manufacturers Life Insurance Company, The Chemo Centryx, Inc. Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Aug 11, 2023	SELL	$22.17 - $51.8 $21,349 - $49,883	-963 Reduced 3.75%	24,743 $1.28 Million
Q3 2022 Nov 03, 2022	SELL	$22.17 - $51.8 $21,349 - $49,883	-963 Reduced 3.75%	24,743 $1.28 Million
Q2 2022 Aug 11, 2023	BUY	$15.36 - $27.51 $47,139 - $84,428	3,069 Added 13.56%	25,706 $636,000
Q2 2022 Aug 15, 2022	BUY	$15.36 - $27.51 $47,139 - $84,428	3,069 Added 13.56%	25,706 $637,000
Q1 2022 Aug 11, 2023	BUY	$22.22 - $39.12 $502,994 - $885,559	22,637 New	22,637 $567,000
Q1 2022 May 20, 2022	SELL	$22.22 - $39.12 $112,055 - $197,282	-5,043 Reduced 18.22%	22,637 $568,000
Q4 2021 Feb 16, 2022	SELL	$18.38 - $40.5 $25,143 - $55,404	-1,368 Reduced 4.71%	27,680 $1.01 Million
Q3 2021 Nov 12, 2021	SELL	$13.18 - $19.83 $32,976 - $49,614	-2,502 Reduced 7.93%	29,048 $497,000
Q2 2021 Aug 12, 2021	BUY	$9.59 - $50.88 $33,354 - $176,960	3,478 Added 12.39%	31,550 $422,000
Q1 2021 May 03, 2021	SELL	$49.53 - $68.4 $86,727 - $119,768	-1,751 Reduced 5.87%	28,072 $1.44 Million
Q4 2020 Feb 12, 2021	BUY	$47.25 - $65.16 $59,771 - $82,427	1,265 Added 4.43%	29,823 $1.85 Million
Q3 2020 Nov 09, 2020	BUY	$46.35 - $61.69 $85,330 - $113,571	1,841 Added 6.89%	28,558 $1.57 Million
Q2 2020 Aug 10, 2020	BUY	$38.58 - $65.07 $18,132 - $30,582	470 Added 1.79%	26,717 $1.46 Million
Q1 2020 May 15, 2020	BUY	$32.73 - $50.78 $23,958 - $37,170	732 Added 2.87%	26,247 $1.06 Million
Q4 2019 Feb 14, 2020	SELL	$6.81 - $39.55 $7,954 - $46,194	-1,168 Reduced 4.38%	25,515 $1.01 Million
Q2 2019 Aug 14, 2019	BUY	$8.31 - $14.85 $221,735 - $396,242	26,683 New	26,683 $248,000
Q3 2018 Nov 14, 2018	SELL	$10.49 - $13.72 $191,106 - $249,950	-18,218 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$10.62 - $13.98 $22,663 - $29,833	-2,134 Reduced 10.49%	18,218 $240,000
Q1 2018 May 15, 2018	BUY	$5.9 - $14.99 $70,221 - $178,410	11,902 Added 140.85%	20,352 $276,000
Q4 2017 Feb 08, 2018	SELL	$5.53 - $8.42 $71,818 - $109,350	-12,987 Reduced 60.58%	8,450 $50,000
Q3 2017 Nov 14, 2017	BUY	$6.5 - $10.69 $139,340 - $229,161	21,437	21,437 $159,000

Others Institutions Holding CCXI

# of Institutions

Shares Held

66.3K

Call Options Held

Put Options Held

View Full List

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account